基本信息
浏览量:0
职业迁徙
个人简介
Dr. Bhargava developed an interest in immunology early in medical school at the Christian Medical College in Vellore, India. He then completed his neurology training at the Southern Illinois University School of Medicine and while there began research in the field of multiple sclerosis (MS). Following his neurology training he completed a 3-year fellowship at the Johns Hopkins University in neuroimmunology and neurological infections focusing on MS clinical care and research. His fellowship training was supported by a Sylvia Lawry physician fellowship award from the National MS Society.
His main research interests include studying the role of inflammation in the meninges in progression of MS disease. He is currently involved in a trial testing the utility of injecting a drug called rituximab into the spinal fluid in patients with progressive MS. He is also developing an animal model of the process of meningeal inflammation to test other potential treatments. This work is supported by awards from the National MS Society, Race to Erase MS and the American Academy of Neurology.
He is also actively involved in studying the role of measuring lipids and small molecule metabolites in serum and plasma to help identify new biomarkers for improved diagnosis and prognosis of the disease. These methods could also help in better tracking the effects of various interventions and in personalizing the treatment of patients with MS.
His main research interests include studying the role of inflammation in the meninges in progression of MS disease. He is currently involved in a trial testing the utility of injecting a drug called rituximab into the spinal fluid in patients with progressive MS. He is also developing an animal model of the process of meningeal inflammation to test other potential treatments. This work is supported by awards from the National MS Society, Race to Erase MS and the American Academy of Neurology.
He is also actively involved in studying the role of measuring lipids and small molecule metabolites in serum and plasma to help identify new biomarkers for improved diagnosis and prognosis of the disease. These methods could also help in better tracking the effects of various interventions and in personalizing the treatment of patients with MS.
研究兴趣
论文共 146 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Dimitrios C. Ladakis,Maria Reyes-Mantilla, Sachin P. Gadani, Jackson W. Mace, Susana C. Dominguez-Penuela, Mayaa J. Appiah, Matthew D. Smith,Pavan Bhargava,Robert J. Fox,Shiv Saidha,Peter A. Calabresi
MULTIPLE SCLEROSIS JOURNALno. 1 (2024): 35-43
Dimitrios C. Ladakis, Edoardo Pedrini,Maria I. Reyes-Mantilla, Muraleetharan Sanjayan,Matthew D. Smith,Kathryn C. Fitzgerald,Carlos A. Pardo,Daniel S. Reich,Martina Absinta,Pavan Bhargava
Neurology Neuroimmunology & Neuroinflammationno. 3 (2024): e200219-e200219
Dimitrios C Ladakis, Kimystian L Harrison,Matthew D Smith, Krista Solem,Sachin Gadani,Larissa Jank,Soonmyung Hwang,Farzaneh Farhadi,Blake E Dewey,Kathryn C Fitzgerald,Elias S Sotirchos,Shiv Saidha,
medRxiv : the preprint server for health sciences (2024)
NEUROLOGIC CLINICSno. 1 (2024): 55-76
Sachin P. Gadani, Saumitra Singh, Sophia Kim, Jingwen Hu, Matthew D. Smith, Peter A. Calabresi,Pavan Bhargava
biorxiv(2024)
Dimitrios Ladakis,Michael Vreones, Joseph Blommer, Kimystian Harrison,Matthew Smith,Eleni Vasileiou,Hussein Moussa,Gelareh Ahmadi, Omar Ezzedin,Anna Duval,Blake Dewey,Jerry Prince,
MULTIPLE SCLEROSIS JOURNAL (2023): 297-297
引用0浏览0引用
0
0
Scott D. Newsome,Fan Tian, Thomas Shoemaker,Kathryn C. Fitzgerald,Sandra D. Cassard, Julie Fiol, Sarah Snoops,David S. Cooper,Jennifer S. R. Mammen,Pavan Bhargava,Ellen M. Mowry,Peter A. Calabresi
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeuticsno. 5 (2023): 1263-1274
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn